NYSE · CIK 0001603015
VIA Via Transportation, Inc.
Insider trading from SEC Form 4. Last filing Feb 17, 2026. Close $32.37 on Oct 9, 2026, +143% from the 52-week low and -40% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Price and insider trades, last year
VIAOct 9, 2026 · close 32.37
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Via Transportation, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Erin Abrams Chief Legal Officer sell | $1.1M 25,000 shares | -17% | - | |
| 52Moderate | Clara Fain Chief Financial Officer sell | $6.5M 150,000 shares | -19% | - | |
| 75Notable | Nechemia Jacob Peres director sell | $17M 388,645 shares | -57% | - | |
| 55Moderate | Daniel Ramot Chief Executive Officer sell | $22M 500,000 shares | -17% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Clara Fain Chief Financial Officer | MOption exercise Class A Common Stock | +4,000 | $6.57 | $26k | 652,693 | Feb 17, 2026 |
| Feb 12, 2026 | Clara Fain Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -4,000 | $0.00 | $0 | 40,860 | Feb 17, 2026 |
| Dec 31, 2025 | Erin Abrams Chief Legal Officer | MOption exercise Class A Common Stock | +417 | $6.57 | $2,740 | 121,431 | Jan 5, 2026 |
| Dec 31, 2025 | Erin Abrams Chief Legal Officer | MOption exercise Class A Common Stock | +5,938 | $8.10 | $48k | 127,369 | Jan 5, 2026 |
| Dec 31, 2025 | Erin Abrams Chief Legal Officer | MOption exercise Stock Option (right to buy)derivative | -417 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Dec 31, 2025 | Erin Abrams Chief Legal Officer | MOption exercise Stock Option (right to buy)derivative | -5,938 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Dec 18, 2025 | Clara Fain Chief Financial Officer | MOption exercise Class A Common Stock | +5,000 | $6.57 | $33k | 648,693 | Dec 19, 2025 |
| Dec 18, 2025 | Clara Fain Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -5,000 | $0.00 | $0 | 44,860 | Dec 19, 2025 |
| Dec 4, 2025 | Clara Fain Chief Financial Officer | MOption exercise Class A Common Stock | +8,259 | $3.73 | $31k | 638,693 | Dec 8, 2025 |
| Dec 4, 2025 | Clara Fain Chief Financial Officer | MOption exercise Class A Common Stock | +5,000 | $6.57 | $33k | 643,693 | Dec 8, 2025 |
| Dec 4, 2025 | Clara Fain Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -8,259 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Dec 4, 2025 | Clara Fain Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -5,000 | $0.00 | $0 | 49,860 | Dec 8, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | JOther Common Stock | -1,152,844 | - | - | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | JOther Class A Common Stock | +1,152,844 | - | - | 1,152,844 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Common Stock | +12,968,287 | - | - | 12,968,287 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | JOther Common Stock | -12,968,287 | - | - | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | JOther Class A Common Stock | +12,968,287 | - | - | 12,968,287 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series A Preferred Stockderivative | -69,030 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series C Preferred Stockderivative | -340,277 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series D Preferred Stockderivative | -3,300,339 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series E Preferred Stockderivative | -7,729,654 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series F Preferred Stockderivative | -650,015 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series G Preferred Stockderivative | -439,486 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 15, 2025 | Exor N.V. director, owner | CConversion Series G-1 Preferred Stockderivative | -439,486 | $0.00 | $0 | 0 | Sep 16, 2025 |
| Sep 11, 2025 | Clara Fain Chief Financial Officer | MOption exercise Common Stock | +72,457 | $3.73 | $270k | 780,434 | Sep 15, 2025 |
| Sep 15, 2025 | Sarah G Smith director | JOther Common Stock | -5,434 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | CConversion Common Stockindirect: See footnote | +20,238 | - | - | 27,915 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Continuation Fund 2021, LP | -48,160 | $43.10 | $2.1M | 635,959 | Sep 15, 2025 |
| Sep 15, 2025 | Guido de Boer director | JOther Common Stock | -5,434 | - | - | 0 | Sep 15, 2025 |
| Sep 11, 2025 | Daniel Ramot Chief Executive Officer | MOption exercise Common Stock | +500,000 | $7.48 | $3.7M | 3,760,236 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Continuation Fund 2021, LP | +680,928 | - | - | 684,119 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | CConversion Common Stockindirect: By Downeast Capital Management, LLC | +135,728 | - | - | 135,728 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Common Stock | -146,014 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | CConversion Common Stockindirect: By 83North VII LP | +659,229 | - | - | 815,479 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | JOther Common Stock | -780,434 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | JOther Common Stockindirect: See footnote | -27,915 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Sarah G Smith director | JOther Class A Common Stock | +5,434 | - | - | 5,434 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Growth Fund I, L.P. | -135,339 | $43.10 | $5.8M | 1,787,179 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | CConversion Common Stockindirect: By Millstein Technology Partners, LLC | +625,124 | - | - | 625,124 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Growth Fund I, L.P. | +1,907,872 | - | - | 1,922,518 | Sep 15, 2025 |
| Sep 15, 2025 | Guido de Boer director | JOther Class A Common Stock | +5,434 | - | - | 5,434 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | CConversion Common Stockindirect: By 83North II Limited Partnership | +4,323,258 | - | - | 4,368,121 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Class A Common Stock | +146,014 | - | - | 146,014 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | JOther Common Stock | -3,760,236 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | JOther Common Stock | +780,434 | - | - | 780,434 | Sep 15, 2025 |
| Sep 15, 2025 | Sarah G Smith director | JOther Stock Option (right to buy)derivative | -65,000 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | JOther Common Stock | -5,434 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | JOther Class A Common Stockindirect: See footnote | +27,915 | - | - | 27,915 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Growth Fund II, L.P. | -24,489 | $43.10 | $1.1M | 323,375 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Growth Fund II, L.P. | +321,570 | - | - | 347,864 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | JOther Common Stockindirect: See footnote | -3,000,000 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | CConversion Common Stockindirect: By 83North FXV III Limited Partnership | +484,076 | - | - | 573,801 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | SOpen-market sale Class A Common Stock | -25,000 | $43.10 | $1.1M | 121,014 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Stock Option (right to buy)derivative | -417 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | SOpen-market sale Common Stock | -150,000 | $43.10 | $6.5M | 630,434 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | JOther Class A Common Stock | +3,760,236 | - | - | 3,760,236 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | JOther Common Stockindirect: By Downeast Capital Management, LLC | -135,728 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | JOther Stock Option (right to buy)derivative | -65,000 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Growth Principals Fund I, L.P. | +38,293 | - | - | 38,587 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Growth Principals Fund I, L.P. | -2,717 | $43.10 | $117k | 35,870 | Sep 15, 2025 |
| Sep 15, 2025 | Sarah G Smith director | JOther Stock Option (right to buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | CConversion Common Stockindirect: By 83North FXV Limited Partnership | +485,756 | - | - | 485,756 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Stock Option (right to buy)derivative | +417 | $0.00 | $0 | 417 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | JOther Stock Option (right to buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | JOther Class A Common Stockindirect: See Footnote | +3,000,000 | - | - | 3,000,000 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Growth Principals Fund II, L.P. | -580 | $43.10 | $25k | 7,663 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | JOther Common Stockindirect: By Millstein Technology Partners, LLC | -625,124 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Growth Principals Fund II, L.P. | +7,620 | - | - | 8,243 | Sep 15, 2025 |
| Sep 11, 2025 | Clara Fain Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -72,457 | $0.00 | $0 | 8,259 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | JOther Common Stock | -5,434 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | JOther Stock Option (right to buy)derivative | -8,259 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | JOther Stock Option (right to buy)derivative | -65,000 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Stock Option (right to buy)derivative | -5,938 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Principals Continuation Fund 2021, LP | -486 | $43.10 | $21k | 6,425 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | JOther Class A Common Stock | +5,434 | - | - | 5,434 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | JOther Class A Common Stock | -846,183 | - | - | 2,914,053 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Principals Continuation Fund 2021, LP. | +6,878 | - | - | 6,911 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | JOther Common Stockindirect: By 83North VII LP | -815,479 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | JOther Common Stockindirect: By 83North II Limited Partnership | -4,368,121 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | JOther Stock Option (right to buy)derivative | +8,259 | $0.00 | $0 | 8,259 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | JOther Class A Common Stockindirect: See Footnote | -3,000,000 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Stock Option (right to buy)derivative | +5,938 | $0.00 | $0 | 5,938 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | JOther Class A Common Stockindirect: By Downeast Capital Management, LLC | +135,728 | - | - | 135,728 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | JOther Stock Option (right to buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Venture Capital Fund VI, L.P. | +2,169,549 | - | - | 2,179,714 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Venture Capital Fund VI, L.P. | -153,444 | $43.10 | $6.6M | 2,026,270 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | JOther Common Stockindirect: By 83North FXV III Limited Partnership | -573,801 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | JOther Stock Option (right to buy)derivative | -54,860 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Venture Capital Fund VI-A, L.P. | -19,768 | $43.10 | $852k | 261,032 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Stock Option (right to buy)derivative | -60,000 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | JOther Class A Common Stockindirect: By Millstein Technology Partners, LLC | +625,124 | - | - | 625,124 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | CConversion Common Stockindirect: By Pitango Venture Capital Fund VI-A, L.P. | +279,491 | - | - | 280,800 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | CConversion Series E Preferred Stockderivativeindirect: See footnote | -16,201 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Daniel Ramot Chief Executive Officer | SOpen-market sale Class A Common Stock | -500,000 | $43.10 | $22M | 2,414,053 | Sep 15, 2025 |
| Sep 15, 2025 | Arnon Dinur director | JOther Common Stockindirect: By 83North FXV Limited Partnership | -485,756 | - | - | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Clara Fain Chief Financial Officer | JOther Stock Option (right to buy)derivative | +54,860 | $0.00 | $0 | 54,860 | Sep 15, 2025 |
| Sep 15, 2025 | Nechemia Jacob Peres director | SOpen-market sale Class A Common Stockindirect: By Pitango Venture Capital Principals Fund VI, L.P. | -3,662 | $43.10 | $158k | 48,344 | Sep 15, 2025 |
| Sep 15, 2025 | Erin Abrams Chief Legal Officer | JOther Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Sep 15, 2025 |
| Sep 15, 2025 | William Peter Nix director | CConversion Series A Preferred Stockderivativeindirect: By Downeast Capital Management, LLC | -135,728 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Sep 15, 2025 | Charles H Rivkin director | CConversion Series F Preferred Stockderivativeindirect: See footnote | -4,037 | $0.00 | $0 | 0 | Sep 15, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Erin AbramsChief Legal Officer
- Arnon Dinurdirector
- Exor N.V.director, owner
- Clara FainChief Financial Officer
- William Peter Nixdirector
- Nechemia Jacob Peresdirector
- Daniel RamotChief Executive Officer
- Charles H Rivkindirector
- Sarah G Smithdirector
- Guido de Boerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.